UCAM和Maria诊断标准用于评估1352例中国人药物性肝损伤文献分析

doi:10.3969/j.issn.1672-5069.2018.06.014

Abstract

Abstract: Objective To summarize the diagnostic value of two diagnostic criteria in diagnosis of patients with drug-induced liver injury（DILI） in Chinese population. Methods We searched publications about Chinese patients in journal full-text database,Wanfang database and pubmed database with keywords of drug-induced liver injury,diagnostic criteria,diagnostic scoring system,RUCAM and Maria scale. Literature review,case reports,and duplication data were excluded. Age,gender and diagnostic criteria were summarized. Results A total of 7 papers including 1352 patients with DILI were included in this analysis. The age range of the patients in this series was 2 to 91 years old. Six papers having 997 cases （97.1%） were diagnosed as DILI,and 30 cases （2.9%） were not diagnosed as DILI by RUCAM scale. Four papers having 736 cases（58.8%） were diagnosed as DILI,and 303 cases（41.2%） were not diagnosed as DILI by Maria scale. Conclusion The diagnostic results of DILI by RUCAM scale and Maria scale were not the same sometimes,which warrants further study.

Key words: Drug-induced liver injury, RUCAM scale, Maria scale, Literature review

Sun Wenjing, Chen Dongfeng.. Literature analysis about RUCAM scale and Maria scale in diagnosis of Chinese patients with drug-induced liver injury[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 881-884.

References

[1] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南. 实用肝脏病杂志,2017,20(2),257-274.
[2] Danan G,Benichou C.Causality assessment of adverse reactions to drug-l. A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries. J Clin Epidemiol,1993,46,1323-1330.
[3] Maria VA,Victiorino RM.Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology,1997,26,664-669.
[4] 滝川一,恩地森一,高森賴雪,他. DDW-J2004ヮ—クショップ药物性肝障害诊断基准の提案. 肝臓,2005,46(2):85-90.
[5] Rochkey DC,Seeff LB,Rochon J,et al.Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the roussel-uclaf causality assessment method. Hpeatology,2010,51(6),2117-2126.
[6] 中华中医药学会肝胆病分会, 中华中医药学会中成药分会. 中草药相关肝损伤临床诊疗指南. 临床肝胆病杂志,2016,32(5),835-843.
[7] 于涛,文卓夫. 两种药物性肝病诊断标准的对比研究. 中国现代医学杂志,2007,17(17),2157-2159.
[8] 刘思纯,马博. 两种急性药物性肝病诊断标准的评价及临床应用比较. 新医学,2009,40(1),21-24.
[9] 高旭东,樊艳华. 药物性肝损伤诊断评分系统的比较及应用体会. 中日友好医院学报,2011,25(5),259-266.
[10] 刘建锋,雷建平,吴于青,等. 3种诊断标准在处治结核病药物性肝损伤诊断的对比分析. 江西医药,2015,50(9):927-930.
[11] 何婷婷,宫馒,白云峰,等. 2种药物性肝损伤诊断指南的应用分析. 中国中药杂志,2016,41(16),3096-3099.
[12] 徐琴,刘浩,张跃新. 3种药物性肝损伤诊断评分系统的应用比较. 中国药房,2016,(27)26,3633-3635.
[13] Zhang P,Ye Y,Yang X,et al.Systematic review on Chinese herbal medicine induced liver injury. Evid-Based Complement Alternat Med,2016,2016,3560812.
[14] 舛本後,恩地森一. 薬物性肝障害の诊断. 肝胆胰,2000,40,887-897.
[15] Bgaud B,Evreux JC,Jouglard J,et al.Unexpected or toxic drug reaction assessment (imputation).Actualization of the method used in France.Therapie,1985,40(2),111-118.
[16] Benchiou C.Criteria of drug-induced liver disorders report of an international consensus meeting. J Hepatol,1990,11(2):272-276.
[17] Garcia-Cortes M,Lucena MI,Pachkoria K,et al.Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther,2008,27(9):780-789.
[18] Hanatani T,Sai K,Tohkin M,et al.A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for international organizations of medical sciences/the Roussel Uclaf Causality Assessment method scale. Pharmacoe-pidemiol Drug Saf,2014,23(9),984-988.
[19] Sanjay S,Girish C.Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury. Eur J Clin Pharmacol,2017,73(4),399-407.
[20] Kullak-Ublick GA,Andrade RJ,Merz M,et al.Drug-induced liver injury:recent advances in diagnosis and risk assessment. Gut,2017,66(6),1154-1164.

Literature analysis about RUCAM scale and Maria scale in diagnosis of Chinese patients with drug-induced liver injury

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[2]	Huang Chunyang, Shan Jing, Liao Huiyu, Huang Yunli, Han Ying, Zhang Xiaodan, Du Xiaofei, Ren Meixin, Bian Xinqu, Liu Yanmin. Clinical and laboratory characteristics of patients with drug-induced liver injury receiving glucocorticoid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 208-211.
[3]	Wu Xiuxin, Zhang Huiyong, Zhang Kai. Changes of plasma microRNA-4284 in patients with anti-tuberculosis drug-induced hepatotoxicity [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 212-215.
[4]	Tong Xin, Fan Hua. Efficacy of bicyclic alcohol on liver function in gastric cancer patients with chemotherapy-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 625-626.
[5]	Liu Cong, Wang Tingting, Zuo Lili, et al. Analysis of patients with drug-induced liver injury in recent 3 years [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 639-640.
[6]	Liu Liangyi, Su Dongyuan. Comparison of clinical and liver pathological features of patients with drug-induced liver injury and autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 463-464.
[7]	Wei Lujia, Li Qingxiang, Ji Qingwei.. Clinical features of amiodarone-induced acute liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 424-426.
[8]	Zhang Dai，Wang Bingyuan.. Novel medicines, new members of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 129-131.
[9]	Wang Yuxia，Du Jian.. Diagnostic and therapeutic progress in anti-thyroid drug -induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 135-138.
[10]	Zheng Kai，Li Hai.. Hepatotoxicity of lipid-lowering agents [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 139-141.
[11]	Zhou Xueshi，Yin Cuilan，Lu Zhonghua，et al.. Drug-induced liver injury：a report of two cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 250-251.
[12]	Du Shuixian, Lu Linlin, Miao Yingxia, et al.. Features of children with drug-induced liver injury:An analysis of 34 cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 607-609.
[13]	Yao Yunjie, Xiao Lang, Yang Caixing, et al. Clinical and pathological features of patients with Chinese herbal drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 441-444.
[14]	Li Zhiqun， Xue Runguo.. Drug-induced liver injury in elderly persons [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 575-577.
[15]	Zhang Bin， Ding Shenhua， Qian Xuemei， et al.. Emodin-induced drug-induced liver injury in rats [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 607-610.